Annual EBIT
-$39.50 M
-$11.27 M-39.94%
December 1, 2023
Summary
- As of February 7, 2025, RVPH annual earnings before interest & taxes is -$39.50 million, with the most recent change of -$11.27 million (-39.94%) on December 1, 2023.
- During the last 3 years, RVPH annual EBIT has fallen by -$37.17 million (-1595.80%).
- RVPH annual EBIT is now -10386.75% below its all-time high of -$376.70 thousand, reached on December 31, 2019.
Performance
RVPH EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$8.36 M
-$513.30 K-6.54%
September 1, 2024
Summary
- As of February 7, 2025, RVPH quarterly earnings before interest & taxes is -$8.36 million, with the most recent change of -$513.30 thousand (-6.54%) on September 1, 2024.
- Over the past year, RVPH quarterly EBIT has increased by +$2.97 million (+26.19%).
- RVPH quarterly EBIT is now -2275.20% below its all-time high of -$352.00 thousand, reached on November 1, 2020.
Performance
RVPH Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$33.27 M
+$2.97 M+8.19%
September 1, 2024
Summary
- As of February 7, 2025, RVPH TTM earnings before interest & taxes is -$33.27 million, with the most recent change of +$2.97 million (+8.19%) on September 1, 2024.
- Over the past year, RVPH TTM EBIT has increased by +$8.61 million (+20.55%).
- RVPH TTM EBIT is now -5281.01% below its all-time high of -$618.30 thousand, reached on March 31, 2020.
Performance
RVPH TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RVPH EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.9% | +26.2% | +20.6% |
| 3 y3 years | -1595.8% | +28.5% | +2.3% |
| 5 y5 years | -10000.0% | +28.5% | +2.3% |
RVPH EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -364.0% | at low | -138.0% | +30.4% | -252.6% | +20.6% |
| 5 y | 5-year | <-9999.0% | at low | -2275.2% | +30.4% | -5281.0% | +20.6% |
| alltime | all time | <-9999.0% | at low | -2275.2% | +30.4% | -5281.0% | +20.6% |
Reviva Pharmaceuticals Holdings EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.36 M(+6.5%) | -$33.27 M(-8.2%) |
| Jun 2024 | - | -$7.85 M(+5.7%) | -$36.24 M(-9.6%) |
| Mar 2024 | - | -$7.42 M(-23.0%) | -$40.08 M(+1.5%) |
| Dec 2023 | -$39.50 M(+39.9%) | -$9.64 M(-14.9%) | -$39.50 M(-5.7%) |
| Sep 2023 | - | -$11.33 M(-3.1%) | -$41.88 M(+22.9%) |
| Jun 2023 | - | -$11.69 M(+70.9%) | -$34.06 M(+22.9%) |
| Mar 2023 | - | -$6.84 M(-43.1%) | -$27.71 M(-1.8%) |
| Dec 2022 | -$28.23 M | -$12.02 M(+242.1%) | -$28.23 M(+41.9%) |
| Sep 2022 | - | -$3.51 M(-34.1%) | -$19.90 M(+6.6%) |
| Jun 2022 | - | -$5.33 M(-27.5%) | -$18.66 M(+25.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$7.36 M(+99.7%) | -$14.93 M(+58.2%) |
| Dec 2021 | -$8.51 M(+265.5%) | -$3.69 M(+61.9%) | -$9.44 M(+52.3%) |
| Sep 2021 | - | -$2.28 M(+42.2%) | -$6.20 M(+29.5%) |
| Jun 2021 | - | -$1.60 M(-14.5%) | -$4.78 M(+21.6%) |
| Mar 2021 | - | -$1.87 M(+319.3%) | -$3.94 M(+46.8%) |
| Dec 2020 | -$2.33 M(+518.4%) | -$446.50 K(+26.8%) | -$2.68 M(+20.0%) |
| Nov 2020 | - | -$352.00 K(-31.3%) | -$2.23 M(+18.7%) |
| Sep 2020 | - | -$512.30 K(-31.9%) | -$1.88 M(+37.4%) |
| Jun 2020 | - | -$752.40 K(+21.7%) | -$1.37 M(+121.7%) |
| Mar 2020 | - | -$618.30 K | -$618.30 K |
| Dec 2019 | -$376.70 K | - | - |
FAQ
- What is Reviva Pharmaceuticals Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings annual EBIT year-on-year change?
- What is Reviva Pharmaceuticals Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly EBIT year-on-year change?
- What is Reviva Pharmaceuticals Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings TTM EBIT year-on-year change?
What is Reviva Pharmaceuticals Holdings annual earnings before interest & taxes?
The current annual EBIT of RVPH is -$39.50 M
What is the all time high annual EBIT for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high annual earnings before interest & taxes is -$376.70 K
What is Reviva Pharmaceuticals Holdings annual EBIT year-on-year change?
Over the past year, RVPH annual earnings before interest & taxes has changed by -$11.27 M (-39.94%)
What is Reviva Pharmaceuticals Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of RVPH is -$8.36 M
What is the all time high quarterly EBIT for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high quarterly earnings before interest & taxes is -$352.00 K
What is Reviva Pharmaceuticals Holdings quarterly EBIT year-on-year change?
Over the past year, RVPH quarterly earnings before interest & taxes has changed by +$2.97 M (+26.19%)
What is Reviva Pharmaceuticals Holdings TTM earnings before interest & taxes?
The current TTM EBIT of RVPH is -$33.27 M
What is the all time high TTM EBIT for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high TTM earnings before interest & taxes is -$618.30 K
What is Reviva Pharmaceuticals Holdings TTM EBIT year-on-year change?
Over the past year, RVPH TTM earnings before interest & taxes has changed by +$8.61 M (+20.55%)